Category: Latest News

  • Penske Automotive posts Q4 earnings shortfall despite revenue topping forecasts

    Penske Automotive posts Q4 earnings shortfall despite revenue topping forecasts

    Penske Automotive Group (NYSE:PAG) reported fourth-quarter results on Wednesday that fell short on profit, even as revenue exceeded Wall Street expectations. Shares of the automotive retailer slipped 1.04% in premarket trading following the release. Adjusted earnings per share came in at $2.91, below the $3.18 consensus estimate. Revenue totaled $7.8 billion, ahead of the $7.62…

  • BorgWarner tops Q4 forecasts, shares tick higher

    BorgWarner tops Q4 forecasts, shares tick higher

    BorgWarner Inc. (NYSE:BWA) reported fourth-quarter results on Wednesday that exceeded Wall Street expectations, prompting a modest rise in its stock. The automotive components supplier posted adjusted earnings per share of $1.35, ahead of the $1.18 consensus estimate. Revenue reached $3.57 billion, beating forecasts of $3.51 billion. Shares gained about 0.4% following the release. Fourth-quarter sales…

  • Taylor Morrison tops Q4 forecasts, shares gain in early trade

    Taylor Morrison tops Q4 forecasts, shares gain in early trade

    Taylor Morrison Home Corporation (NYSE:TMHC) delivered fourth-quarter results on Wednesday that surpassed analyst expectations, posting solid performance despite a softer housing backdrop. Shares of the homebuilder rose 1.91% in premarket trading following the announcement. The company reported adjusted earnings per share of $1.91, ahead of the $1.73 consensus estimate. Revenue totaled $1.96 billion, slightly exceeding…

  • FDA clears Merck’s KEYTRUDA and KEYTRUDA QLEX for platinum-resistant ovarian cancer

    FDA clears Merck’s KEYTRUDA and KEYTRUDA QLEX for platinum-resistant ovarian cancer

    The U.S. Food and Drug Administration has granted approval to Merck & Co. (NYSE:MRK) for the use of KEYTRUDA and KEYTRUDA QLEX, in combination with paclitaxel, with or without bevacizumab, to treat adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer whose tumors express PD-L1, the company said Monday. The authorization applies to…

  • Transocean lands $184 million in fresh offshore drilling deals

    Transocean lands $184 million in fresh offshore drilling deals

    Transocean Ltd (NYSE:RIG) said it has secured new contracts and extensions valued at a combined $184 million for its offshore drilling fleet. The company disclosed that its Transocean Encourage rig received a seven-well contract extension, which is expected to add roughly 365 days of work. The additional term is slated to commence in the first…

  • Smurfit Westrock shares slide after Q4 earnings disappoint

    Smurfit Westrock shares slide after Q4 earnings disappoint

    Smurfit Westrock plc (NYSE:SW) posted fourth-quarter results on Wednesday that missed profit expectations, even as revenue came in broadly in line with forecasts. Shares of the paper-based packaging group fell 3.30% in premarket trading following the announcement. The company reported adjusted earnings per share of $0.34 for the quarter, well below the $0.50 consensus estimate.…

  • Solstice Advanced Materials falls short on Q4 profit despite revenue growth

    Solstice Advanced Materials falls short on Q4 profit despite revenue growth

    Solstice Advanced Materials Inc. (NASDAQ:SOLS) reported fourth-quarter results on Wednesday that missed earnings expectations, even as the company delivered solid year-over-year revenue growth. Shares slipped 0.06% following the release. The specialty materials maker posted adjusted earnings per share of $0.26, below the $0.40 analysts had forecast. Revenue rose 8% from a year earlier to $987…

  • Avantor shares drop more than 5% as turnaround efforts fail to excite investors

    Avantor shares drop more than 5% as turnaround efforts fail to excite investors

    Avantor, Inc. (NYSE:AVTR) posted fourth-quarter results on Wednesday that met Wall Street expectations, but the update did little to reassure investors about the progress of its restructuring plan. Shares of the life sciences tools provider declined 5.6% in premarket trading following the announcement. The company reported adjusted earnings per share of $0.22, in line with…

  • SiteOne shares slip over 2% despite narrower Q4 loss and margin gains

    SiteOne shares slip over 2% despite narrower Q4 loss and margin gains

    SiteOne Landscape Supply, Inc. (NYSE:SITE) posted fourth-quarter results on Wednesday showing a smaller-than-expected loss, but its cautious 2026 outlook weighed on the stock in early trading. Shares fell 2.61% in premarket action following the release. The landscaping products distributor reported a net loss of $0.20 per share for the quarter, slightly better than analysts’ expectations…

  • Hilton tops Q4 forecasts, shares tick up on earnings strength

    Hilton tops Q4 forecasts, shares tick up on earnings strength

    Hilton Worldwide Holdings Inc. (NYSE:HLT) posted fourth-quarter results on Wednesday that came in ahead of Wall Street expectations, helping lift its shares modestly in early trading. The hotel operator reported adjusted earnings per share of $2.08, exceeding the $2.02 consensus estimate. Revenue reached $3.09 billion, also above forecasts of $2.99 billion. Shares gained about 0.43%…